Tiara C Willie1, Jamila K Stockman2, Rachel Perler3, Trace S Kershaw4. 1. Chronic Disease Epidemiology, Yale School of Public Health, New Haven, CT. Electronic address: tiara.willie@yale.edu. 2. Division of Infectious Diseases and Global Public Health, Department of Medicine and Director of the Disparities Core of the UCSD Center for AIDS Research, La Jolla, CA. 3. Yale School of Public Health, New Haven, CT. 4. Social and Behavioral Sciences, Yale School of Public Health, and Director of T32 Training, Center for Interdisciplinary Research on AIDS, New Haven, CT.
Abstract
PURPOSE: To assess the association between state-level intimate partner violence (IPV) prevalence and HIV diagnosis rates among women in the United States and investigate the modifying effect of state IPV health care policies. METHODS: Data on HIV diagnosis rates were collected from HIV surveillance data from 2010 to 2015, and IPV prevalence data were collected from the National Intimate Partner and Sexual Violence Survey from 2010 to 2012. States were coded for IPV health care policies on training, screening, reporting, and insurance discrimination. RESULTS: States with higher IPV prevalence was associated with higher HIV diagnoses among women (B = 0.02; 95% confidence interval [CI] = 0.003, 0.04; P = .02). State policies were a significant effect modifier (B = -0.05; 95% CI = -0.07, -0.02; P < .001). Simple slopes revealed that the association between IPV and HIV diagnosis rates was stronger in states with low IPV protective health care policies (B = 0.09; CI = 0.06, 0.13; P < .001) and moderate IPV protective policies (B = 0.05; 95% CI = 0.02, 0.07, P < .001), but not in states with high IPV protective policies (B = -0.009; 95% CI = -0.04, 0.02; P = .59). CONCLUSIONS: HIV prevention programs should target IPV and link to community resources. IPV-related policies in the health care system may protect the sexual health of women experiencing IPV.
PURPOSE: To assess the association between state-level intimate partner violence (IPV) prevalence and HIV diagnosis rates among women in the United States and investigate the modifying effect of state IPV health care policies. METHODS: Data on HIV diagnosis rates were collected from HIV surveillance data from 2010 to 2015, and IPV prevalence data were collected from the National Intimate Partner and Sexual Violence Survey from 2010 to 2012. States were coded for IPV health care policies on training, screening, reporting, and insurance discrimination. RESULTS: States with higher IPV prevalence was associated with higher HIV diagnoses among women (B = 0.02; 95% confidence interval [CI] = 0.003, 0.04; P = .02). State policies were a significant effect modifier (B = -0.05; 95% CI = -0.07, -0.02; P < .001). Simple slopes revealed that the association between IPV and HIV diagnosis rates was stronger in states with low IPV protective health care policies (B = 0.09; CI = 0.06, 0.13; P < .001) and moderate IPV protective policies (B = 0.05; 95% CI = 0.02, 0.07, P < .001), but not in states with high IPV protective policies (B = -0.009; 95% CI = -0.04, 0.02; P = .59). CONCLUSIONS: HIV prevention programs should target IPV and link to community resources. IPV-related policies in the health care system may protect the sexual health of women experiencing IPV.
Authors: Ying Li; Caitlin M Marshall; Hilary C Rees; Annabelle Nunez; Echezona E Ezeanolue; John E Ehiri Journal: J Int AIDS Soc Date: 2014-02-13 Impact factor: 5.396
Authors: Tamora A Callands; Shantesica M Gilliam; Katelyn M Sileo; Erica N Taylor; Josalin J Hunter-Jones; Nathan B Hansen Journal: AIDS Behav Date: 2020-11-12
Authors: Ansley B Lemons-Lyn; Amy R Baugher; Sharoda Dasgupta; Jennifer L Fagan; Sharon G Smith; R Luke Shouse Journal: Am J Prev Med Date: 2021-03-31 Impact factor: 6.604
Authors: Natalie M Leblanc; Kamila Alexander; Sierra Carter; Hugh Crean; Ladrea Ingram; James Kobie; James McMahon Journal: Womens Health Rep (New Rochelle) Date: 2020-05-19
Authors: Yilu Qin; Carolina Price; Ronnye Rutledge; Lisa Puglisi; Lynn M Madden; Jaimie P Meyer Journal: J Int Assoc Provid AIDS Care Date: 2020 Jan-Dec
Authors: Rosemary M Delabre; Adeline Bernier; Flor Sánchez; Antoine Vilotitch; Sophocles Chanos; Maria Luisa Cosmaro; Harriet Langanke; Coline Mey; Cary James; Sascha B Duken; Vincent Schlegel; Richard Stranz; Kai J Jonas; Bruno Spire; Daniela Rojas Castro Journal: PLoS One Date: 2021-02-17 Impact factor: 3.240
Authors: Tiara C Willie; Laurel Sharpless; Mauda Monger; Trace S Kershaw; Wendy B Mahoney; Jamila K Stockman Journal: Womens Health (Lond) Date: 2022 Jan-Dec
Authors: Elizabeth Barr; Karine Dubé; Shobha Swaminathan; Carlos Del Rio; Danielle M Campbell; Marta Paez-Quinde; Susan E Cohn Journal: HIV Res Clin Pract Date: 2021-06-18